BLYX Trademark

Trademark Overview

On Friday, November 11, 2016, a trademark application was filed for BLYX with the United States Patent and Trademark Office. The USPTO has given the BLYX trademark a serial number of 87234070. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 25, 2024. This trademark is owned by AstraZeneca AB. The BLYX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

General Information

Serial Number87234070
Word MarkBLYX
Filing DateFriday, November 11, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 25, 2024
Registration Number5436015
Registration DateTuesday, April 3, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 25, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Tuesday, November 15, 2016NEW APPLICATION ENTERED
Thursday, November 17, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 17, 2016ASSIGNED TO EXAMINER
Thursday, November 17, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 17, 2016NON-FINAL ACTION E-MAILED
Thursday, November 17, 2016NON-FINAL ACTION WRITTEN
Thursday, May 11, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 11, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 12, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 31, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 20, 2017PUBLISHED FOR OPPOSITION
Friday, February 9, 2018NOTICE OF ALLOWANCE CANCELLED
Tuesday, February 27, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 3, 2018REGISTERED-PRINCIPAL REGISTER
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 20, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 9, 2018TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, February 27, 20181(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 3, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 25, 2024CANCELLED SEC. 8 (6-YR)
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

blyx diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal